Literature DB >> 6702861

Comparative effects of prazosin and atenolol on plasma lipids in hypertensive patients.

J Rouffy, J Jaillard.   

Abstract

Adverse modifications of blood lipid fractions are thought to be an additional risk factor in hypertensive patients treated with some antihypertensive drugs. The purpose of this study was to compare the changes in concentrations of lipid fractions in patients treated with either the cardioselective beta blocker atenolol or the selective alpha 1 blocker prazosin. When used in approximately equipotent doses for antihypertensive effect, prazosin and atenolol demonstrated different effects on lipid metabolism. Prazosin lowered total levels of cholesterol, low-density lipoprotein cholesterol and B-apolipoproteins, but increased the levels of high-density lipoprotein cholesterol, high-density lipoprotein2 cholesterol and A1-apolipoproteins. Changes opposite to those induced by prazosin were observed during atenolol therapy.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6702861     DOI: 10.1016/0002-9343(84)90966-5

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  6 in total

1.  Metabolic effects of carteolol and dilevalol in essential hypertension.

Authors:  T Baba; K Takebe; T Tomiyama
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 2.  The effects of antihypertensive drugs on serum lipids and lipoproteins. II. Non-diuretic drugs.

Authors:  R P Ames
Journal:  Drugs       Date:  1986-10       Impact factor: 9.546

Review 3.  The effects of diuretics and adrenergic-blocking agents on plasma lipids.

Authors:  J J Rohlfing; J D Brunzell
Journal:  West J Med       Date:  1986-08

4.  Alterations in cellular cholesterol metabolism following administration of 6-hydroxydopamine to rabbits.

Authors:  N M O'Meara; R A Devery; D Owens; P B Collins; A H Johnson; G H Tomkin
Journal:  Br J Pharmacol       Date:  1992-02       Impact factor: 8.739

Review 5.  Serum lipoproteins during treatment with antihypertensive drugs.

Authors:  P Weidmann; C Ferrier; H Saxenhofer; D E Uehlinger; B N Trost
Journal:  Drugs       Date:  1988       Impact factor: 9.546

Review 6.  Doxazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in mild or moderate hypertension.

Authors:  R A Young; R N Brogden
Journal:  Drugs       Date:  1988-05       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.